Name: DNA Vaccines Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: PH1518
Price: 4350 USD
Availability: InStock

DNA Vaccines Market Size Share Growth Opportunities and Forecast 2022

DNA Vaccines Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global DNA Vaccines Market is segmented&nbsp;By Type (Human DNA Vaccines, Animal DNA Vaccines),&nbsp;By Application (Human Diseases, Veterinary Diseases),&nbsp;By End User (Human Health, Animal Health, Research),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global DNA Vaccines Market is expected to grow at a high <a href="https://www.datamintelligence.com/download-sample/dna-vaccines-market">CAGR of 42.03%</a> during the forecasting period (2022-2029).
</blockquote>

<h2>Why purchase the report?</h2>

<ul>
	<li>
	Visualize the composition of the Global DNA Vaccines Market across each indication, regarding type and application highlighting the critical commercial assets and players.
	</li>
	<li>
	Identify business opportunities in Global DNA Vaccines Market by analyzing trends and co-development deals.
	</li>
	<li>
	Excel data sheet with thousands of data points of the Global DNA Vaccines Market levels 4/5 segmentation.
	</li>
	<li>
	PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
	</li>
	<li>
	Product mapping in excel for the essential Global DNA Vaccines Market of all major market players.
	</li>
</ul>

<h2>Who can benefit from this report?</h2>

<ul>
	<li>
	Raw Material Suppliers/ Buyers
	</li>
	<li>
	Product Suppliers/ Buyers
	</li>
	<li>
	Industry Investors/Investment Bankers
	</li>
	<li>
	<a href="https://www.datamintelligence.com/enquiry/dna-vaccines-market">Education &amp; Research Institutes</a>
	</li>
	<li>
	Research Professionals
	</li>
	<li>
	Emerging Companies
	</li>
	<li>
	Manufacturers
	</li>
</ul>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>
		Market Snippet by Type
		</li>
		<li>
		Market Snippet by Application
		</li>
		<li>
		Market Snippet by End User
		</li>
		<li>
		Market Snippet by Region
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Rising prevalence of infectious diseases
				</li>
				<li>
				Increasing number of antibiotics resistant pathogens
				</li>
				<li>
				Technological advancement
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				Certain side effects associated with vaccines
				</li>
				<li>
				High cost of immunization
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis&nbsp;</h3>

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	<h3>Pipeline Analysis&nbsp;</h3>
	</li>
	<li>
	<h3>By Type</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Attractiveness Index, By Type
			</li>
		</ol>
		</li>
		<li>
		Human DNA Vaccines

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Animal DNA Vaccines
		</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Attractiveness Index, By Application
			</li>
		</ol>
		</li>
		<li>
		Human Diseases

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
			</li>
		</ol>
		</li>
		<li>
		Veterinary Diseases
		</li>
	</ol>
	</li>
	<li>
	<h3>By End User</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Attractiveness Index, By End User
			</li>
		</ol>
		</li>
		<li>
		Human Health

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
			</li>
		</ol>
		</li>
		<li>
		Animal Health
		</li>
		<li>
		Research
		</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia-Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Market Competitive Landscape</h3>

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor DNA Vaccines Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Market Company Profiles</h3>

	<ol>
		<li>
		Sanofi Aventis SA *

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		GlaxoSmithKline Plc
		</li>
		<li>
		Merck &amp; Co., Inc.
		</li>
		<li>
		Pfizer Inc.
		</li>
		<li>
		Novartis AG
		</li>
		<li>
		Advance Bioscience Laboratories Inc.
		</li>
		<li>
		Indian Immunologicals Ltd.
		</li>
		<li>
		Xenetic Biosciences Inc.
		</li>
		<li>
		QED Biosciences Inc.
		</li>
		<li>
		Elanco Animal Health Incorporated
		</li>
		<li>
		Boehringer-Ingelheim GmbH
		</li>
		<li>
		Plumbline Life Sciences, Inc.
		</li>
		<li>
		Eisai Pharmaceuticals Co., Ltd.
		</li>
		<li>
		Inovio Pharmaceuticals, Inc.
		</li>
		<li>
		Astellas Pharma Inc.
		</li>
		<li>
		Bharat Biotech International Ltd.
		</li>
		<li>
		Dendreon Corporation
		</li>
		<li>
		GE Healthcare Life Sciences Inc.
		</li>
	</ol>
	</li>
	<li>
	<h3>Premium Insights</h3>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 1 Global DNA Vaccines Market Value, By Type, 2021,2025 &amp; 2029($ Million)

Table 2 Global DNA Vaccines Market Value, By Application, 2021,2025 &amp; 2029($ Million)

Table 3 Global DNA Vaccines Market Value, By End User, 2021,2025 &amp; 2029($ Million)

Table 4 Global DNA Vaccines Market Value, By Region, 2021,2025 &amp; 2029($ Million)

Table 5 Global DNA Vaccines Market Value, By Type, 2021,2025 &amp; 2029($ Million)

Table 6 Global DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 7 Global DNA Vaccines Market Value, By Application, 2021,2025 &amp; 2029($ Million)

Table 8 Global DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 9 Global DNA Vaccines Market Value, By End User, 2021,2025 &amp; 2029($ Million)

Table 10 Global DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 11 Global DNA Vaccines Market Value, By Region, 2021,2025 &amp; 2029($ Million)

Table 12 Global DNA Vaccines Market Value, By Region, 2017-2028 ($ Million)

Table 13 North America DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 14 North America DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 15 North America DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 16 North America DNA Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 17 South America DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 18 South America DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 19 South America DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 20 South America DNA Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 21 Europe DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 22 Europe DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 23 Europe DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 24 Europe DNA Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 25 Asia-Pacific DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 26 Asia-Pacific DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 27 Asia-Pacific DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 28 Asia-Pacific DNA Vaccines Market Value, By Country, 2017-2028 ($ Million)

Table 29 Middle East &amp; Africa DNA Vaccines Market Value, By Type, 2017-2028 ($ Million)

Table 30 Middle East &amp; Africa DNA Vaccines Market Value, By Application, 2017-2028 ($ Million)

Table 31 Middle East &amp; Africa DNA Vaccines Market Value, By End User, 2017-2028 ($ Million)

Table 32 Sanofi Aventis SA: Overview

Table 33 Sanofi Aventis SA: Product Portfolio

Table 34 Sanofi Aventis SA: Key Developments

Table 35 GlaxoSmithKline Plc: Overview

Table 36 GlaxoSmithKline Plc: Product Portfolio

Table 37 GlaxoSmithKline Plc: Key Developments

Table 38 Merck &amp; Co., Inc.: Overview

Table 39 Merck &amp; Co., Inc.: Product Portfolio

Table 40 Merck &amp; Co., Inc.: Key Developments

Table 41 Pfizer Inc.: Overview

Table 42 Pfizer Inc.: Product Portfolio

Table 43 Pfizer Inc.: Key Developments

Table 44 Novartis AG: Overview

Table 45 Novartis AG: Product Portfolio

Table 46 Novartis AG: Key Developments

Table 47 Advance Bioscience Laboratories Inc.: Overview

Table 48 Advance Bioscience Laboratories Inc.: Product Portfolio

Table 49 Advance Bioscience Laboratories Inc.: Key Developments

Table 50 Indian Immunologicals Ltd.: Overview

Table 51 Indian Immunologicals Ltd.: Product Portfolio

Table 52 Indian Immunologicals Ltd.: Key Developments

Table 53 Xenetic Biosciences Inc.: Overview

Table 54 Xenetic Biosciences Inc.: Product Portfolio

Table 55 Xenetic Biosciences Inc.: Key Developments

Table 56 QED Biosciences Inc.: Overview

Table 57 QED Biosciences Inc.: Product Portfolio

Table 58 QED Biosciences Inc.: Key Developments

Table 59 Zoties Inc.: Overview

Table 60 Zoties Inc.: Product Portfolio

Table 61 Zoties Inc.: Key Developments

&nbsp;

List of Figures

Figure 1 Global DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 2 Global DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 3 Global DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 4 Global DNA Vaccines Market Share, By Region, 2018 &amp; 2028 (%)

Figure 5 Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 6 Global DNA Vaccines Market Y-o-Y Growth, By Type, 2018-2028 (%)

Figure 7 Human DNA Vaccines: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 8 Animal DNA Vaccines: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 9 Global DNA Vaccines Market Y-o-Y Growth, By Application, 2018-2028 (%)

Figure 10 Human Diseases: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 11 Veterinary Diseases: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 12 Global DNA Vaccines Market Y-o-Y Growth, By End User, 2018-2028 (%)

Figure 13 Human Health: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 14 Animal Health: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 15 Research: Global DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 16 Global DNA Vaccines Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 17 North America DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 18 North America DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 19 North America DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 20 North America DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 21 North America DNA Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 22 South America DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 23 South America DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 24 South America DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 25 South America DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 26 South America DNA Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 27 Europe DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 28 Europe DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 29 Europe DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 30 Europe DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 31 Europe DNA Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 32 Asia-Pacific DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 33 Asia-Pacific DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 34 Asia-Pacific DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 35 Asia-Pacific DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 36 Asia-Pacific DNA Vaccines Market Share, By Country, 2018 &amp; 2028 (%)

Figure 37 Middle East &amp; Africa DNA Vaccines Market Value, 2017-2028 ($ Million)

Figure 38 Middle East &amp; Africa DNA Vaccines Market Share, By Type, 2018 &amp; 2028 (%)

Figure 39 Middle East &amp; Africa DNA Vaccines Market Share, By Application, 2018 &amp; 2028 (%)

Figure 40 Middle East &amp; Africa DNA Vaccines Market Share, By End User, 2018 &amp; 2028 (%)

Figure 41 Sanofi Aventis SA: Financials

Figure 42 GlaxoSmithKline Plc: Financials

Figure 43 Merck &amp; Co., Inc.: Financials

Figure 44 Pfizer Inc.: Financials

Figure 45 Novartis AG: Financials

Figure 46 Advance Bioscience Laboratories Inc.: Financials

Figure 47 Indian Immunologicals Ltd.: Financials

Figure 48 Xenetic Biosciences Inc.: Financials

Figure 49 QED Biosciences Inc.: Financials

Figure 50 Zoties Inc.: Financials